Insights into Potential Targets for Therapeutic Intervention in Epilepsy
Epilepsy is a chronic brain disease that affects approximately 65 million people worldwide. However, despite the continuous development of antiepileptic drugs, over 30% patients with epilepsy progress to drug-resistant epilepsy. For this reason, it is a high priority objective in preclinical researc...
Main Authors: | Cecilia Zavala-Tecuapetla, Manola Cuellar-Herrera, Hiram Luna-Munguia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8573 |
Similar Items
-
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-12-01) -
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01) -
Comparative analysis of three decades' experience in the management of pregnant women with epilepsy: a real-life scenario
by: Réka Válóczy, et al.
Published: (2023-09-01) -
Sleep and Epilepsy
by: Kyung Min Kim, et al.
Published: (2023-06-01) -
Neuropharmacology of Antiseizure Drugs
by: Tahir Hakami
Published: (2021-09-01)